Clinical Trial Update: Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I [Phase 3]

View source ↗

Summary

Phase 3 study of Aldurazyme in patients with mucopolysaccharidosis type I (Hurler and Hurler-Scheie) has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome
• Hurler-scheie Syndrome
• Mucopolysaccharidosis Type

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I, Hurlers Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2009-08-19